|
17 April 2008
|
New data confirm pramipexole (Mirapexin®/Sifrol®) can significantly reduce sleep disturbance for people with Restless Legs Syndrome (RLS)
|
 |
 |
|
|
23 May 2006
|
A meta-analysis of clinical studies shows: Spiriva® consistently reduces exacerbations and associated hospitalisations in patients with COPD
|
|
|
|
|
19 May 2006
|
Results from the ESPRIT trial published in The Lancet confirm that the combination of dipyridamole and acetylsalicylic acid (ASA)٭ is superior to ASA alone in the prevention of recurrent stroke
|
|
|
|
|
23 February 2006
|
Boehringer Ingelheim provides update on study arms of Aptivus® (tipranavir)
|
|
|
|
|
18 January 2006
|
Most extensive thromboembolic disease clinical trial program launched by Boehringer Ingelheim
|
|
|
|
|
17 October 2005
|
New data confirm Pramipexole delivers sustained efficacy for patients with Restless Legs Syndrome
|
|
|
|
|
19 September 2005
|
Scientific Media
Restless Legs Syndrome (RLS) - New data confirm pramipexole relieves symptoms and significantly improves patients’ quality of life
|
|
|
|
|
19 September 2005
|
General Media
New hope for Restless Legs Syndrome (RLS) - Pramipexole relieves symptoms and improves patients’ quality of life
|
|
|
|
|
19 September 2005
|
Head-to-head study shows COPD patients achieve significantly better lung function improvements with the combination of Spiriva® and formoterol than the combination of salmeterol and fluticasone propionate
|
|
|
|
|
06 September 2005
|
General Media
Preliminary studies suggest potential metabolic effects of Micardis® (telmisartan)
|
|
|
|
|
06 September 2005
|
Scientific Media
Preliminary studies suggest potential metabolic effects of Micardis® (telmisartan)
|
|
|
|
|
11 August 2005
|
First of its Kind Urinary Incontinence Study Reveals Many Women With Stress Urinary Incontinence Symptoms Receive Off-Label Medications or None at All
|
|
|
|
|
28 July 2005
|
Positive opinion in Europe for tipranavir -
New data support its use as powerful treatment against HIV drug resistance
|
|
|
|
|
13 July 2005
|
Boehringer Ingelheim and Genentech announce early termination of a phase IIIb/IV study of TNKase/Metalyse used prior to angioplasty in patients with severe heart attacks
|
|
|
|
|
30 June 2005
|
Boehringer Ingelheim publishes clinical trials online
|
|
|
|
|
23 June 2005
|
New research data on pramipexole show 95 percent effectiveness and long-term relief from the symptoms of Restless Legs Syndrome
|
|
|
|
|
20 June 2005
|
Scientific Media
New data shows Telmisartan provides superior blood pressure control in the risky morning hours
|
|
|
|
|
06 June 2005
|
NICE recommends Aggrenox® (dipyridamole + ASA) as first line treatment for prevention of occlusive vascular events after stroke or transient ischaemic attack
|
|
|
|
|
31 May 2005
|
Boehringer Ingelheim and Genentech suspend enrollment into phase IIIb/IV study of TNKaseTM/ Metalyse® used prior to angioplasty in patients with severe heart attacks
|
|
|
|
|
24 May 2005
|
TIPHON study shows Spiriva® (tiotropium) significantly improves health-related quality of life in patients with COPD
|
|
|
|
|
13 May 2005
|
New study confirms the excellent efficacy and tolerability of MicardisPlus®
in older patients with systolic hypertension
|
|
|
|
|
11 April 2005
|
Unique new study suggests significant benefits of Yentreve® in combination with pelvic floor muscle training for women with stress urinary incontinence
|
|
|
|
|
01 April 2005
|
New data shows telmisartan (Micardis®/Pritor®) provides effective and well-tolerated blood pressure lowering in chronic kidney disease patients
|
|
|
|
|
08 March 2005
|
Large clinical study results show pramipexole rapidly relieves Restless Legs Syndrome symptoms and improves sleep and depressed mood
|
|
|
|
|
28 February 2005
|
Efficacy of investigational anti-HIV agent tipranavir demonstrated by new data
|
|
|
|
© 2005 - 2007 Boehringer Ingelheim International GmbH, Germany. All rights reserved.
